Be Ready for the New Combo HIV Med Biktarvy

June 2018

Biktarvy (bik-TAR-vee, bictegravir/emtricitabine/tenofovir alafenamide) will be a new first-line option for HIV.

Think of it as a complete HIV regimen in one pill.

Biktarvy combines a new integrase inhibitor, bictegravir...with two nucleoSIDE/nucleoTIDE reverse transcriptase inhibitors (NRTIs), emtricitabine and tenofovir alafenamide.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Anticoagulants Lean Toward Eliquis for the Best Balance of Efficacy and Safety in Atrial Fib
Asthma Consider Tiotropium or Biologics for Severe Asthma
Diabetes Don't Advise Routine Glucose Monitoring if Results Won't Be Used
Depression Stay Alert for Depression in Teens
Naloxone Co-Prescribe Naloxone for Patients at Opioid Overdose Risk
Practice Use These Tips to Determine Whether Marketing Is Just Hype
Epinephrine Be Prepared for New Epinephrine Auto-Injector Barriers and Options
Toxicology Expect Large Vitamin K Doses for Bleeding Due to Laced Synthetic Cannabinoids
OTC Products Don't Jump to Lumify to Relieve Red Eyes
HIV & AIDS Be Ready for the New Combo HIV Med Biktarvy
Nebulizers Be Aware of Differences Between Lonhala Magnair and Other Nebulizers
Antithrombotics Think of Antiplatelets for Arterial Clots and Anticoagulants for Venous Clots
Antithrombotics Know When to Hold Antithrombotics Around Regional Anesthesia
Infectious Diseases Stay Alert for a New, Concentrated Rabies Immune Globulin Option

Be Ready for the New Combo HIV Med Biktarvy

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents